| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e99229bbb6293674d4ce1a70b40a3b0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate |
2006-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bce17ece1bae07b0edbdc8c7866911f |
| publicationDate |
2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006229585-A1 |
| titleOfInvention |
Drug delivery to the crystalline lens and other ocular structures |
| abstract |
A method of delivering a drug or other compound to structures of the eye. A conduit through which a drug is introduced penetrates the eye so as to be located proximate an ocular structure, such as the crystalline lens or the retina, but does not penetrate the ocular structure. A drug is introduced adjacent the ocular structure using the conduit and is directed into the ocular structure using iontophoresis. In one embodiment, the conduit operates as one of the electrodes for the iontophoresis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013133712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-2008451-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109602498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7824372-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006253151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007237722-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007237797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007231360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7976520-B2 |
| priorityDate |
2005-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |